Neuraxis Inc 's ability to collect accounts receivable sequentially worsen to 18.95, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Neuraxis Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 19 days, from 17 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 193 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 1585 to 1759.

What is Receivable Turnover Ratio?
What is Neuraxis Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NRXS Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	236.86 %	57.98 %	-20 %	106.3 %	-12.65 %
Y / Y Revenue Change	115.72 %	79.52 %	27.19 %	21.72 %	46.21 %
Receivable Turnover Ratio (TTM)	18.95	20.94	21.11	18.54	19.23
NRXS's Total Ranking	# 1759	# 1585	# 414	# 1555	# 488
Accounts Receivable average collection period days	19	17	17	20	19
Seq. Receivable Change	12.45 %	96.73 %	80.36 %	-15.57 %	-47.27 %
Seq. Revenue Change	19.95 %	66.08 %	19.31 %	-9.25 %	-0.18 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 82
Healthcare Sector	# 194
Overall Market	# 1759

Receivable Turnover Ratio Statistics
High	Average	Low
2.18	1.21	0.61
(Mar 31 2024)		(Mar 31 2026)

NRXS Company Profile • Back to NRXS Efficiency Comparisons • Compare NRXS Receivables Turnover Ratio to its Competitors

Financial Statements
Neuraxis Inc 's Accounts Receivable	$ 0 Millions	Visit NRXS's Balance sheet
Neuraxis Inc 's Sales TTM	$ 5 Millions	Visit NRXS's Income Statement
Sources of NRXS's Revenues		Visit NRXS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NRXS's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NRXS's Growth Rates	NRXS's Roa	NRXS's Inventory Turnover Ratio	NRXS's Dividend Comparisons
NRXS's Profitability Ratios	NRXS's Roi	NRXS's Asset Turnover Ratio	NRXS's Dividend Growth
NRXS's Valuation Ratios	NRXS's Roe	NRXS's Financial Strength Ratios	NRXS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Innovative Eyewear Inc	31.49	$ 3.412 Millions	$ 0.108 Millions
Cv Sciences Inc	31.22	$ 12.066 Millions	$ 0.387 Millions
Ginkgo Bioworks Holdings Inc	30.60	$ 111.863 Millions	$ 3.656 Millions
Innovage Holding Corp	30.33	$ 989.707 Millions	$ 32.630 Millions
Invo Fertility Inc	30.20	$ 7.531 Millions	$ 0.249 Millions
Wave Life Sciences Ltd	26.88	$ 81.746 Millions	$ 3.041 Millions
Igc Pharma Inc	26.21	$ 1.101 Millions	$ 0.042 Millions
Sonida Senior Living Inc	23.90	$ 525.973 Millions	$ 22.008 Millions
Marpai Inc	23.52	$ 16.635 Millions	$ 0.707 Millions
Agenus Inc	22.44	$ 132.693 Millions	$ 5.914 Millions
U S Physical Therapy Inc	22.40	$ 812.203 Millions	$ 36.251 Millions
Nutriband Inc	22.15	$ 1.618 Millions	$ 0.073 Millions
Lineage Cell Therapeutics Inc	20.02	$ 13.083 Millions	$ 0.654 Millions
Hims and Hers Health Inc	19.65	$ 2,578.494 Millions	$ 131.228 Millions
Neuraxis Inc	18.95	$ 5.316 Millions	$ 0.281 Millions
China Pharma Holdings Inc	18.55	$ 3.914 Millions	$ 0.211 Millions
Bausch Health Companies Inc	18.42	$ 10,853.000 Millions	$ 589.250 Millions
Arvinas Inc	17.26	$ 316.700 Millions	$ 18.350 Millions
Nrx Pharmaceuticals Inc	17.25	$ 3.394 Millions	$ 0.197 Millions
Polomar Health Services, Inc.	17.19	$ 3.172 Millions	$ 0.185 Millions
Anika Therapeutics Inc	16.70	$ 121.370 Millions	$ 7.266 Millions
Lifemd Inc	16.48	$ 163.363 Millions	$ 9.915 Millions
Longeveron Inc	16.43	$ 1.187 Millions	$ 0.072 Millions
Bioage Labs Inc	15.82	$ 10.355 Millions	$ 0.655 Millions
Vaxart Inc	15.09	$ 243.064 Millions	$ 16.108 Millions
Medicinova Inc	15.02	$ 0.920 Millions	$ 0.061 Millions
Voyager Therapeutics Inc	14.71	$ 34.459 Millions	$ 2.343 Millions
Halozyme Therapeutics Inc	14.68	$ 1,663.738 Millions	$ 113.332 Millions
Nexgel Inc	14.52	$ 11.810 Millions	$ 0.813 Millions
Skinhealth Systems Inc	14.42	$ 289.224 Millions	$ 20.051 Millions

Date modified: 2026-09-12T06:26:59+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.